[ORGANIZATION]
EMA
Featured in 3 tracked stories · first seen
Situations
FDA approves Rasonque for pancreatic cancer; lung cancer use
36 clusters · 292 sources · last updated
Latest: Daraxonrasib shows clinical promise for RAS-mutant lung cancer
On 26 August 2026, the U.S. Food and Drug Administration (FDA) granted expedited approval to daraxonrasib, marketed as Rasonque, for treating adults with metastatic pancreatic ductal adenocarcinoma (PDAC). Developed by R
Desogestrel contraceptive brain tumor risk
4 clusters · 8 sources · last updated
Latest: Health agencies warn of brain tumor risk from certain contraceptives
The European Medicines Agency (EMA) and various national health authorities have issued warnings regarding a rare association between meningioma—a type of brain tumor—and the long-term use of hormonal contraceptives cont
Also covered in
-
New Zealand manages rising respiratory illness and workplace impacts
[HEALTH] · 2 sources ·